| ²é¿´: 714 | »Ø¸´: 4 | ||
| ±¾Ìû²úÉú 1 ¸ö ·ÒëEPI £¬µã»÷ÕâÀï½øÐв鿴 | ||
yin198716гæ (ÕýʽдÊÖ)
|
[ÇóÖú]
ÇóÕâ¾ä»°µÄ·Òë
|
|
| A further problem is that although this therapy is highly specific£¬patients are not selected on the basis of pathways of sensitivity or resistance in their tumors£® |
» ²ÂÄãϲ»¶
318Çóµ÷¼Á
ÒѾÓÐ8È˻ظ´
Çóµ÷¼Á
ÒѾÓÐ7È˻ظ´
0703»¯Ñ§
ÒѾÓÐ13È˻ظ´
307·Ö²ÄÁÏרҵÇóµ÷¼Á
ÒѾÓÐ4È˻ظ´
0855Çóµ÷¼Á²ÄÁÏ
ÒѾÓÐ8È˻ظ´
332Çóµ÷¼Á
ÒѾÓÐ9È˻ظ´
¼×´¼/¶þÂÈ 1:15¹ýÖù×Ó
ÒѾÓÐ3È˻ظ´
272Çóµ÷¼Á
ÒѾÓÐ4È˻ظ´
Ò»Ö¾Ô¸Î÷±±Å©ÁÖÐóÄÁר˶336·ÖÇóµ÷¼Á
ÒѾÓÐ3È˻ظ´
Çóµ÷¼Á
ÒѾÓÐ10È˻ظ´

vivanslum
ľ³æ (ÕýʽдÊÖ)
- ·ÒëEPI: 94
- Ó¦Öú: 10 (Ó×¶ùÔ°)
- ½ð±Ò: 5587.9
- É¢½ð: 21
- ºì»¨: 4
- Ìû×Ó: 547
- ÔÚÏß: 600.7Сʱ
- ³æºÅ: 1801798
- ×¢²á: 2012-05-07
- רҵ: »·¾³¹¤³Ì

2Â¥2012-10-30 16:58:48
һدһ»®
½ð³æ (ÕýʽдÊÖ)
- ·ÒëEPI: 14
- Ó¦Öú: 2 (Ó×¶ùÔ°)
- ½ð±Ò: 2731.6
- É¢½ð: 6
- ºì»¨: 5
- Ìû×Ó: 411
- ÔÚÏß: 219.7Сʱ
- ³æºÅ: 2038367
- ×¢²á: 2012-09-30
- ÐÔ±ð: GG
- רҵ: ½ðÊôÓлú»¯Ñ§
3Â¥2012-11-03 11:12:32
_xmg
ľ³æ (ÕýʽдÊÖ)
- Ó¦Öú: 207 (´óѧÉú)
- ½ð±Ò: 3655.9
- É¢½ð: 21
- ºì»¨: 8
- Ìû×Ó: 629
- ÔÚÏß: 1114.1Сʱ
- ³æºÅ: 1920373
- ×¢²á: 2012-08-01
- ÐÔ±ð: GG
- רҵ: µç»¯Ñ§
4Â¥2012-11-04 10:32:39
gaofenzi2010
ÖÁ×ðľ³æ (ÖøÃûдÊÖ)
- Ó¦Öú: 221 (´óѧÉú)
- ½ð±Ò: 14481
- É¢½ð: 87
- ºì»¨: 12
- Ìû×Ó: 2188
- ÔÚÏß: 3039.9Сʱ
- ³æºÅ: 1009164
- ×¢²á: 2010-04-30
- ÐÔ±ð: GG
- רҵ: Óлú¸ß·Ö×Ó¹¦ÄܲÄÁÏ
5Â¥2012-11-04 12:58:29














»Ø¸´´ËÂ¥
